ArticleOrthopedic reviews2026
Outcome Assessment of Cementless Total Hip Arthroplasty in Patients with Late-stage Avascular Necrosis of the Femoral Head in Vietnam, 2011 - 2021.
Article in Orthopedic reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The progression of avascular necrosis to the point of femoral head collapse necessitates total hip arthroplasty surgery as a treatment intevention. Despite its widespread use, this surgical procedure is often associated with a notable incidence of failure and various postoperative complications. This study aimed to evaluate the outcomes of cementless total hip arthroplasty (CTHA) in Vietnamese patients diagnosed with late-stage avascular necrosis of the femoral head (AVNFH). Methods: From Sep 2011 to Dec 2021, 150 patients were diagnosed with unilateral AVNFH at stages IV, V, and VI at the 108 Military Central Hospital. These patients underwent laboratory tests, CTHA, and assessments of hip function at three intervals: before surgical procedure, 12 months after surgery, and 48 months post-surgery. Results: Among the 150 patients with AVNFH, the femurs were classified as type B (80.7%), type A (10%), and type C (9.3%). Of these patients, 62.0% had articular head diameters of 32mm, while 38.0% had diameters of 36mm. The bearing surface pairings used in hip arthroplasty included 63.3% metal-polyethylene and 36.7% ceramic-ceramic. Regarding implant size, 86.7% used size 10-13 femoral stems, 6.0% used size 9, and 7.4% used size 14-15. In-hospital following surgery, there were no reports of thrombosis, deep infection, femoral fracture, or acetabular fracture. Meanwhile, 80% of cases had the acetabulum positioned in an intermediate alignment, whereas 4.0% and 16.0% were in varus and valgus positions, respectively. Patients with AVNFH in stages IV, V, and VI showed significant improvement in mobility, with pain levels decreasing to 0.0% and Harriss Hip scores increasing to approximately 85 points. At 12 months postoperatively, 16.0%, 52.0%, 21.2%, and 16.7% of patients exhibited bone platforms, bone welds, radiolucent lines, and calcar osteolysis, respectively. These figures increased to 23.0%, 89.3%, 27.3%, and 30.7%, respectively, after 48 months. Complications at 12 months included 2.0% superficial infection, 0.7% deep infection, and prosthetic joint loosening. At 48 months, patients experienced deep infection, hip dislocation, and prosthetic joint loosening, each occurring in 1.3% of cases. Conclusion: With the posterior approach, CTHA for Vietnamese patients with AVNFH stages IV, V, and VI demonstrated favorable and promising outcomes. Intraoperative complications were minor, and no significant issues were observed during the 12- and 48-month postoperative follow-up periods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.